LEADER 02562nam0 2200577 i 450 001 VAN0127164 005 20230627025905.577 017 70$2N$a9783030315030 100 $a20200226d2019 |0itac50 ba 101 $aeng 102 $aCH 105 $a|||| ||||| 200 1 $aStatistical Methods in Biomarker and Early Clinical Development$fLiang Fang, Cheng Su editors 210 $aCham$cSpringer$d2019 215 $axii, 348 p.$cill.$d24 cm 500 1$3VAN0236999$aStatistical Methods in Biomarker and Early Clinical Development$91733535 606 $a62P10$xApplications of statistics to biology and medical sciences; meta analysis [MSC 2020]$3VANC024649$2MF 606 $a92Cxx$xPhysiological, cellular and medical topics [MSC 2020]$3VANC024650$2MF 606 $a92B15$xGeneral Biostatistics [MSC 2020]$3VANC026442$2MF 606 $a62R07$xStatistical aspects of big data and data science [MSC 2020]$3VANC026514$2MF 606 $a68T09$xComputational aspects of data analysis and big data [MSC 2020]$3VANC035916$2MF 610 $aBiomarker Development$9KW:K 610 $aBiomarker book$9KW:K 610 $aBiomarker data$9KW:K 610 $aBiomarker testing$9KW:K 610 $aBiomarkers$9KW:K 610 $aBiostatistics$9KW:K 610 $aClinical Trials$9KW:K 610 $aClinical pharmacology$9KW:K 610 $aClinical pharmacology in drug development$9KW:K 610 $aDrug development statistics$9KW:K 610 $aEarly clinical development$9KW:K 610 $aMachine learning medicine$9KW:K 610 $aPersonalized medicine$9KW:K 610 $aPharmaceutical Development$9KW:K 610 $aPharmacodynamics$9KW:K 610 $aPrecision medicine$9KW:K 610 $aPredictive biomarker$9KW:K 610 $aTranslational Medicine$9KW:K 620 $aCH$dCham$3VANL001889 702 1$aFang$bLiang$3VANV098604 702 1$aSu$bCheng$3VANV098605 712 $aSpringer $3VANV108073$4650 801 $aIT$bSOL$c20240405$gRICA 856 4 $uhttp://doi.org/10.1007/978-3-030-31503-0$zE-book ? Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth 899 $aBIBLIOTECA DEL DIPARTIMENTO DI MATEMATICA E FISICA$1IT-CE0120$2VAN08 912 $fN 912 $aVAN0127164 950 $aBIBLIOTECA DEL DIPARTIMENTO DI MATEMATICA E FISICA$d08CONS e-book 1751 $e08eMF1751 20200226 996 $aStatistical Methods in Biomarker and Early Clinical Development$91733535 997 $aUNICAMPANIA